The revolutionary impact of immune checkpoint inhibitors (ICIs) has transformed cancer care, yielding unprecedented durable responses across a spectru
Read Full Article To Earn PointsDaily news to keep you up to date
Participate and win exciting prizes
Participate and win cash vouchers
Get updates on the latest events happening around the world
1.
Are patients with advanced cancer receiving treatment aligned with their goals?
2.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
3.
Month-Long Wait Times Caused by US Physician Shortage.
4.
Reasons Behind Refusing Stem Cell Transplantation in Certain Myeloma Patients.
5.
Cancer patients rarely use ancestry testing.
1.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
2.
Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies
3.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
4.
The Benefits and Side Effects of Bortezomib in the Fight Against Cancer
5.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
4.
Current Scenario of Cancer- Q&A Session to Close the Gap
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation